T1	Participants 851 1091	Cats were assigned to one of four treatment groups that received either high dose huIFN-Î±2a (10(5) IU/kg q24h; 12 cats), AZT (5 mg/kg q12h; 10 cats, both of these treatments (12 cats) or placebo (10 cats). All cats were treated for 6 weeks.
